Proactive Investors - Run By Investors For Investors

Breakfast News - Energiser Investments; Imaginatik; RedstoneConnect and more...

Breakfast News -  Energiser Investments; Imaginatik; RedstoneConnect and more...

Small Cap Breakfast

Set menu

AIM:

Total number of AIM Companies (Incl Susp):

936*

Total number of AIM Companies trading:

880*

*as at close of business  26 May 2018

Standard List**  of Main Market:

Total number of Standard List Companies

(Incl Susp):

137*

Total number of Standard List Companies trading:

124*

*as at close of business  26 May 2018

NEX Growth Market:

Total number of NEX Growth Market Companies (Incl Susp):

86*

Total number of NEX Growth Market Companies trading:

84*               

*as at close of business  26 May 2018                             

*A corporate client of Hybridan LLP

**  Standard Listing as defined by Hybridan LLP to be a business with strictly operational activity

                           

Dish of the day

No Joiners Today

Off the menu   

Mandicon has left NEX Exchange

 

What’s cooking in the IPO kitchen?

NEX Exchange

Stratmin Global Resources RTO of Signature Gold  a specialist Australian gold exploration company focused on the exploration and development of large-scale Intrusion Related Gold System. Offer TBA. Due 4 June.  Will leave AIM under rule 41.

AIM

Block Energy— UK based oil exploration and production company whose main country of operation is the Republic of Georgia.  Raising £4m. Mkt cap £9.3m. Due early June.

Codemasters Group— video game developer and publisher, specialising in high quality racing games.  Offer TBA. Seeking £15m in primary. Due 1 June.

Strongbow Exploration (TSX:SBW) intends to dual list on AIM.  Holds rights to the South Crofty underground tin mine, a former producing tin mine located in the towns of Pool and Camborne, Cornwall . The project is estimated to require the Company to raise £25 million over the next 18 months to progress to a production decision. Offer TBS. Due June.

Maestrano Group,  a software company with operations in Australia (main country of operation), the UK, US and the UAE, is looking to join AIM.  Cloud based automated management data system. Raising £6m at 15p. Mkt Cap £12m. Due 30 May.

Yew Grove REIT—newly formed Company will pursue its investment objective by investing in a diversified portfolio of Irish commercial property. Offer TBA. Due Late May

 

Main Market (Premium)

Utilico Global Income—  new actively managed income investment trust raising up to £100 million . Due 22 June.

On the horizon (speculative and rumoured IPOs)

Press reports that Abu Dhabi's VPS Healthcare which operates about 20 hospitals and over 125 medical centers across the Middle East, Europe and India,  is considering a London IPO.                            

                               

Breakfast Buffet

Energiser Investments (LON:ENGI) 1.15p £1.4m

Final results. “During the year we sold the investment properties at Wellingborough for a consideration of £2.8m, the majority of the priority return from the Kingswood 12 unit development loan was also received in the year for a total of £773,000.”

Net assets have increased slightly to £1.77m (2016: £1.75m) following disposals and repayment of debt. This results in a net asset value per share at the year end of 1.43p (2016: 1.41p). Cash of £2m.

“The Group’s strategy is to invest in quoted and unquoted companies to achieve capital growth.  Our focus is predominantly on investment opportunities within the real estate sector. In 2018 we will continue to actively manage our investments and uncover and transact in further accretive investment opportunities.”

 

Belvoir Lettings (LON:BLV) 104p £36.34m

AGM statement from the UK's largest property franchise. “Trading during the first four months of the current financial year has continued well and is in line with the Board's expectations”.

“Our franchisees, across all three brands, have completed on ten portfolio transactions under our Assisted Acquisitions programme adding £3.2m network revenue, nearly 2,500 managed properties and £0.3m p.a. of recurring Management Service Fees ("MSF"). The Group is seeing an unprecedented number of smaller independent lettings agents choosing to withdraw from the sector in the face of increased legislation and the previously announced ban on tenant fees, now expected in the Spring of 2019.  As a result, there remains a strong pipeline of further opportunities to underpin the Group's growth target for 2018.” Pe c.9x.  Yield > 6.5%.

 

Advanced Oncotherapy (LON:AVO) 52p £78.3m

Technological update:

“The LIGHT system has been designed to electronically control the fast delivery of protons to the tumour site. This unique ability provides the opportunity to alter the exact amount of radiation that is given to every part of the tumour in a few micro-seconds. This feature is invaluable for accurate tumour targeting and side-effect minimisation, particularly in the case of moving targets. As part of its testing and regulatory plan, the Company has developed a Time-of-Flight ("TOF") measurement system which measures the speed of the beam; this allows the system to measure the energy of each proton pulse, which is a very important clinical parameter.” “With much of the technological development now de-risked, the Company is on target to have a system capable of treating superficial tumours by the end of Q3 2018.”

 

Imaginatik  (LON:IMTK) 1.1p £2.47m

“Update on funding and formal sale process

Imaginatik, the innovation company, today provides an update on its funding requirements.

Further to the Company's trading statement on 1 May 2018, the Company confirms that it is now exploring short term additional funding in order to successfully progress the ongoing formal sale process. As previously announced, the Board is aiming to announce the outcome of the process by the end of May.”

 

RedstoneConnect (LON:REDS) 110p £22.9m

FYJan18 results from the provider of technology and services for smart buildings.

Revenue up 15% to £47.6m. Adjusted EBITDA up 60% to £3.2m. Net cash £1.2m.

Has also Announced the proposed sale of the Systems Integration and Managed Services divisions for a total consideration of £23m. “Following the disposal of the Managed Services and Systems Integration business the Group will reduce in size operationally. However, we plan to use the funds realised from the disposal to accelerate the growth of our Software business. This growth will initially be organic through the development of our direct and indirect sales channels, both in the UK and overseas. However, should we identify appropriate targets, we also plan to make acquisitions of businesses which either have a customer base that can be migrated onto our OneSpace platform or offer complementary technology that can add value to the OneSpace platform.”

 

Gaming Realms (LON:GMR) 8p £22.75m

“The developer, publisher and licensor of mobile real money and social games, is pleased to announce that it has signed a three-year licensing deal with Sony Pictures Television (SPT). The deal will see Gaming Realms create and host the new gaming website millionairegames.com on its proprietary platform following the successful return of 'Who Wants To Be A Millionaire?' in the United Kingdom.

The  new millionairegames.com si­te went live in tandem with the return of 'Who Wants To Be A Millionaire?' on ITV, marking the 20th anniversary of SPT's hit global game show. The deal will also see the creation and launch of a Slingo game format of 'Who Wants To Be A Millionaire?' later this summer.”

 

 ProPhotonix (LON:PPIX) 10.75p £7.4m

The “high technology designer and manufacturer of LED illumination systems and laser diode modules, with operations in Ireland and the UK, announces it has delivered a three-meter-long RGB LED line light [perhaps the largest of its kind]  to a world class inkjet printer manufacturer. The modular COBRA RGB offers superior brightness, excellent colour tuning capability, and fast switching speeds.  This 3m COBRA RGB provides extremely bright, uniform, multispectral illumination ideally suited in line scan applications such as print inspection and calibration.” 

“This project demonstrates how our products can be configured to deliver the ideal solution to a customer's specific use case without having to consider a customized solution."

 

Medaphor Group (LON:MED) 11.25p £10.2m

The intelligent ultrasound software and simulation company, “has installed its first BodyWorks Eve, Point of Care ultrasound (PoCUS) simulator, at NYU School of Medicine, in the simulation laboratory of the affiliated Veterans Affairs New York Harbor Healthcare System NY Campus, New York, USA.

BodyWorks Eve is an ultra-realistic female manikin-based simulator designed specifically for doctors looking to train in PoCUS and will aid the teaching of PoCUS to medical students, residents and faculty. Complete with over 100 real patient scans and over 10,000 pathology variations across cardiac, lung, transabdominal and pelvic ultrasound, it is the most dynamic simulator available for ultrasound scenario training with structured educational content, based on the International Federation of Emergency Medicine (IFEM) PoCUS curriculum guidelines.”

 

ImmuPharma (LON:IMM) 27.6p £38.49m

The specialist drug discovery and development company, announced further analysis of the results from its pivotal Phase III trial of Lupuzor™, its lead programme for the potential breakthrough compound for Lupus. This new data follows the top-line trial results published on 17 April 2018 and which may create new commercial value for Lupuzor™.  As previously announced, across the whole study population, in those patients who had anti-dsDNA autoantibodies, Lupuzor™ demonstrated a superior response rate over placebo (61.5% vs 47.3%, p=0.0967), although these results were not statistically significant. Further data however showed statistically significant results in  the European cohort.

ImmuPharma will discuss these findings with its regulatory, scientific and medical experts in order to formulate discussions with the regulatory agencies on next steps.  In parallel, the Company will also continue to progress discussions with potential corporate partners. 

 

Altus Strategies (LON:ALS) 7.12p £12.55m

“Altus Strategies Plc (AIM:ALS), the Africa focused exploration project generator, announces that its 100% owned subsidiary Aterian Resource Ltd has been granted new exploration licences, targeting zinc and copper in Morocco.

Highlights:

Ammas, Takzim Est and Arfa licences granted totalling 87.55 km2 in Morocco

Ammas licence located 3km along strike of Hajjar VMS zinc-copper mine

Takzim Est licence located 6km east of the Company's Takzim zinc project

Arfa licence located in the Oriental province of north-eastern Morocco

 

Discovery of quartz stockworks and gossanous outcrops at Ammas”.

 

 

This document, which does not constitute research, has been issued by Hybridan LLP for information purposes only and should not be construed in any circumstances as an offer to sell or solicitation of any offer to buy any security or other financial instrument, nor shall it, or the fact of its distribution, form the basis of, or be relied upon in connection with, any contract relating to such action. This document has no regard for the specific investment objectives, financial situation or needs of any specific entity and is not a personal recommendation to anyone. Recipients should make their own investment decisions based upon their own financial objectives and financial resources and, if any doubt, should seek advice from an investment advisor.

The information contained in this document is based on materials and sources that are believed to be reliable; however, they have not been independently verified and are not guaranteed as being accurate. This document is not intended to be a complete statement or summary of any securities, markets, reports or developments referred to herein. No representation or warranty, either express or implied, is made or accepted by Hybridan LLP, its members, directors, officers, employees, agents or associated undertakings in relation to the accuracy, completeness or reliability of the information in this document nor should it be relied upon as such.

Any and all opinions expressed are current opinions as of the date appearing on this document only. Any and all opinions expressed are subject to change without notice and Hybridan LLP is under no obligation to update the information contained herein. To the fullest extent permitted by law, none of Hybridan LLP, its members, directors, officers, employees, agents or associated undertakings shall have any liability whatsoever for any direct or indirect or consequential loss or damage (including lost profits) arising in any way from use of all or any part of the information in this document.

This document should not be relied upon as being an independent or impartial view of the subject matter and, for the avoidance of doubt, does not constitute “independent investment research” for the purposes of the Financial Conduct Authority rules. The individuals who prepared this document may be involved in providing other financial services to the company or companies referenced in this document or to other companies who might be said to be competitors of the company or companies referenced in this document. As a result both Hybridan LLP and the individual members, directors, officers and/or employees who prepared this document may have responsibilities that conflict with the interests of the persons who receive this document. Hybridan LLP and/or connected persons may, from time to time, have positions in, make a market in and/or effect transactions in any investment or related investment mentioned herein and may provide financial services to the issuers of such investments.

In the UK, this document is directed at and is for distribution only to persons who (i) fall within Article 19(5) (persons who have professional experience in matters relating to investments) or Article 49(2) (a) to (d) (high net worth companies, unincorporated associations, etc) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (as amended) or (ii) are Professional Clients or Eligible Counterparties (as those terms are defined in the rules of the Financial Conduct Authority) of Hybridan LLP (all such persons referred to in (i) and (ii) together being referred to as “relevant persons”). This document must not be acted on or relied up on by persons who are not relevant persons. For the purposes of clarity, this document is not intended for and should not be relied upon by persons who would be classified as Retail Clients (as defined by the rules of the Financial Conduct Authority).

Neither this document nor any copy of part thereof may be distributed in any other jurisdictions where its distribution may be restricted by law and persons into whose possession this document comes should inform themselves about, and observe, any such restrictions. Distribution of this report in any such other jurisdictions may constitute a violation of UK or US securities law, or the law of any such other jurisdictions.

Hybridan LLP and/or its associated undertakings may from time-to-time provide investment advice or other services to, or solicit such business from, any of the companies referred to in this document. Accordingly, information may be available to Hybridan LLP that is not reflected in this material and Hybridan LLP may have acted upon or used the information prior to or immediately following its publication. In addition, Hybridan LLP, the members, directors, officers and/or employees thereof and/or any connected persons may have an interest in the securities, warrants, futures, options, derivatives or other financial instrument of any of the companies referred to in this document and may from time-to-time add or dispose of such interests.

Neither the whole nor any part of this document may be duplicated in any form or by any means. Neither should this document, or any part thereof, be redistributed or disclosed to anyone without the prior consent of Hybridan LLP.

Hybridan LLP is a limited liability partnership registered in England and Wales, registered number OC325178, and is authorised and regulated by the Financial Conduct Authority and is a member of the London Stock Exchange. Any reference to a partner in relation to Hybridan LLP is to a member of Hybridan LLP or an employee with equivalent standing and qualifications. A list of the members of Hybridan LLP is available for inspection at the registered office, 2 Jardine House, The Harrovian Business Village, Bessborough Road, Harrow, Middlesex HA1 3EX.

© Proactive Investors 2019

Proactive Investors Australia PTY LTD ACN:132787654 ABN:19132787654.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use